What is the approach to managing hyperandrogenism in women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Approach to Hyperandrogenism in Women

Begin with first-line laboratory testing using total testosterone (TT) and free testosterone (FT) measured by LC-MS/MS, combined with clinical assessment of hirsutism (using modified Ferriman-Gallwey score), acne, and androgenic alopecia to establish the diagnosis of hyperandrogenism. 1, 2

Initial Diagnostic Evaluation

Clinical Assessment

  • Hirsutism: Score terminal hair growth in male-pattern areas using the modified Ferriman-Gallwey method; a score ≥6 indicates hirsutism in Caucasian populations 3, 4
  • Acne: Document persistent or severe acne, particularly if resistant to standard treatments 2
  • Androgenic alopecia: Assess for male-pattern hair loss 2
  • Virilization signs: Check for clitoromegaly, voice deepening, increased muscle mass—these suggest more severe androgen excess or possible tumor 2, 5
  • Menstrual patterns: Document oligomenorrhea or amenorrhea 2
  • Metabolic signs: Look for acanthosis nigricans (insulin resistance marker), truncal obesity, elevated BMI 2

First-Line Laboratory Tests

Use LC-MS/MS methodology when available for highest accuracy 1, 2:

  • Total testosterone (TT) 1, 2
  • Free testosterone (FT): Measured by equilibrium dialysis or ammonium sulfate precipitation, or calculated using free androgen index (FAI) if mass spectrometry unavailable 1, 2
  • Important caveat: Avoid direct immunoassay methods for FT due to poor accuracy at low serum concentrations 1

Second-Line Laboratory Tests (if TT/FT not elevated)

  • Androstenedione (A4) 1
  • DHEAS (dehydroepiandrosterone sulfate) 1, 2
  • Note: These have poorer specificity than testosterone measurements 1
  • LH/FSH ratio: A ratio >2 suggests PCOS 2, 6

Exclusion of Secondary Causes

Screen for these conditions before diagnosing PCOS 2, 7:

  • TSH: Rule out thyroid disease 2
  • Prolactin: Exclude hyperprolactinemia 2
  • 17-hydroxyprogesterone: Screen for nonclassic congenital adrenal hyperplasia 2, 3
  • 24-hour urinary free cortisol or late-night salivary cortisol: Consider if Cushing's syndrome suspected 2

Red Flags for Androgen-Secreting Tumors

Urgent imaging required if 2, 3:

  • Very high testosterone levels (typically >150-200 ng/dL)
  • Rapid onset of symptoms
  • Progressive virilization
  • Age of onset atypical for PCOS

Metabolic Screening

All women with confirmed hyperandrogenism require metabolic assessment 2:

  • Fasting glucose and 2-hour oral glucose tolerance test: Screen for diabetes and insulin resistance 2
  • Fasting lipid panel: Assess cardiovascular risk 2

Treatment Algorithm

First-Line Pharmacologic Treatment

Combined oral contraceptives (COCs) are the first-line treatment for hyperandrogenism 2, 6:

  • Effectively regulate menstrual cycles 2, 6
  • Reduce hyperandrogenism 2, 6
  • Improve acne and hirsutism 2, 6
  • Prevent endometrial hyperplasia in anovulatory women 8

Second-Line: Antiandrogen Therapy

Add antiandrogens for severe hirsutism or inadequate response to COCs 3, 4:

  • Cyproterone acetate: Most effective antiandrogen; decreases hair density, regrowth speed, and pigmentation 3
  • Spironolactone: Androgen receptor blocker 5, 4
  • Flutamide: Alternative androgen receptor blocker 5
  • 5α-reductase inhibitors: Can be combined with above 4
  • Critical point: Must combine with contraception due to teratogenic risk 3

Adjunctive Treatments

  • Topical eflornithine hydrochloride: For facial hirsutism 4
  • Cosmetic treatments: Laser therapy, electrolysis, intense pulsed light for long-term hair removal 4
  • Metformin: Consider for insulin resistance, particularly in PCOS 7

Lifestyle Modifications

Weight loss should be vigorously encouraged in overweight/obese patients 2, 8:

  • Improves metabolic complications 2
  • Ameliorates insulin resistance 8
  • May improve ovulatory function 8

Timeline for Treatment Response

Set realistic expectations with patients 4:

  • Acne: Responds relatively rapidly (weeks to months) 4
  • Hirsutism: Improvements observed at 3 months minimum, typically 6-8 months 4
  • Androgenic alopecia: Slowest response; may require 12-18 months, and response is variable 4

Common Pitfalls to Avoid

  • Do not use direct immunoassays for free testosterone—they are highly inaccurate 1
  • Do not diagnose PCOS without excluding secondary causes (thyroid disease, hyperprolactinemia, Cushing's, CAH) 2, 7
  • Do not overlook psychological impact of visible symptoms like hirsutism and acne—address as part of comprehensive care 2, 6
  • Do not miss androgen-secreting tumors—maintain high suspicion with very elevated androgens or rapid symptom onset 2, 3
  • Remember SHBG fluctuations affect TT and FAI results (influenced by age, weight, medications like oral contraceptives) 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hyperandrogenism Diagnosis and Evaluation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Hyperandrogenism in women].

Presse medicale (Paris, France : 1983), 2013

Research

Androgen excess: Investigations and management.

Best practice & research. Clinical obstetrics & gynaecology, 2016

Research

[Hyperandrogenism, adrenal dysfunction, and hirsutism].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2020

Guideline

Diagnosis and Treatment of Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hyperandrogenism.

Indian journal of pediatrics, 2023

Research

Diagnosis and therapy of hyperandrogenism.

Bailliere's clinical obstetrics and gynaecology, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.